SeaSpine Holdings Corporation
- Jurisdiction
United States - LEI
5493006QNC6E00LJ7M10 - ISIN
US81255T1088 (SPNE )- Sectors
Scores
- Fair value (Benjamin Graham formula)
- N/A
- Financial strength (Piotroski F-Value)
-
3
/ 9
- Fundamental strength relative to industry (Mohanram G-Value)
-
5
/ 7
Profile
SeaSpine Holdings Corporation, a medical technology company, focuses on the design, development, and commercialization of surgical solutions for the treatment of spinal disorders in the United States and internationally. Read full profile
Fundamentals
- Net revenue
€195.96M - Gross margin
60.0% - EBIT
-€56.36M - EBIT margin
-28.8% - Net income
-€55.30M - Net margin
-28.2%
Statement period: - (published )
Stock price
Dividends
No dividend payouts
Analyst ratings
No analyst ratings available
Insider Transactions
No insider transactions in the last 90 days. View older insider transactions
Earnings Calls
Earnings Calls
Latest earnings call: November 1, 2022 (Q3 2022)